Empresa Liminal BioSciences Inc.
Acciones
PJ2
CA53272L2021
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 51 | 14/07/08 | |
Director of Finance/CFO | 51 | 02/03/22 | |
Patrick Sartore
PSD | President | 49 | 01/01/06 |
Gary Bridger
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/05/19 |
Director/Board Member | 67 | 14/05/14 | |
Shrinal Inamdar
IRC | Investor Relations Contact | - | - |
Marie Iskra
LAW | General Counsel | 48 | 01/09/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gary Bridger
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/05/19 |
Director/Board Member | 67 | 14/05/14 | |
Alek Krstajic
CHM | Chairman | 60 | 01/09/20 |
Neil Klompas
BRD | Director/Board Member | 52 | 01/05/19 |
Eugene Siklos
BRD | Director/Board Member | 60 | 01/09/20 |
Director/Board Member | 63 | 01/05/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 3 249 534 | 1 258 903 ( 38,74 %) | 0 | 38,74 % |
Información de la empresa
Liminal BioSciences, Inc.
440, boulevard Armand-Frappier Suite 300
H7V 4B4, Laval
+450 781 0115
http://www.liminalbiosciences.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+1,12 % | 42,59 mil M | |
+6,77 % | 40,65 mil M | |
+47,58 % | 40,57 mil M | |
-11,96 % | 26,77 mil M | |
+6,01 % | 24,81 mil M | |
-24,92 % | 18,17 mil M | |
+27,16 % | 12,05 mil M | |
-3,63 % | 11,7 mil M | |
+7,30 % | 11,1 mil M |